Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival

(2012) C. P. Venner et al.   BLOOD

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

(2012) Stefan Cordes et al.   CANCER

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide

(2011) Giovanni Palladini et al.   ANNALS OF HEMATOLOGY

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

(2011) M. T. Cibeira et al.   BLOOD

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

(2011) D. E. Reece et al.   BLOOD

Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management

(2010) Morie A. Gertz   AMERICAN JOURNAL OF HEMATOLOGY

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

(2010) Morie A. Gertz et al.   LEUKEMIA & LYMPHOMA

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38  MAPK pathway

(2010) J. Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture

(2010) L A Sikkink et al.   Cell Death & Disease

Currents Concepts on the Immunopathology of Amyloidosis

(2009) Anupama Bhat et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

(2008) A. D. Wechalekar et al.   HAEMATOLOGICA